Drugs & Pharmaceuticals

In a sleepy moment, I had an inspiration.

Last year, I wrote an article about Antibe Therapeutics' potentially revolutionary drug (1), ATB-

It's been a tough time to be an anti-vaxxer, and it just got tougher.

 

If you happen to be in the Houston area and are looking for some top-notch medical, here's a great place... ...to avoid: The Hotze Health & Wellness Center.  

The Pew Charitable Trust just posted its analysis of the antibacterial pipeline, providing two separate analyses, one for 

Back in April, I wrote about EIDD-2801, now called molnupiravir, (1) at which time I wr

Sorry, anti-vaxxers. If you're hoping to find some bad news about the COVID vaccines, you've come to the wrong site. Perhaps you should try AlienDNA.com, or I'm out of my F#####Mind.org. I've got nothing but good news. 

I have been saying for years that for a pull incentive to actually function as an incentive, it must be large enough to motivate investors and large Pharma to get back into antibiotic R&D.

To update a very old adage: "The Pain is Always Less Painful on the Other Side of the Border."  Same old, same old, but worse